SCHEMBL115658

SCHEMBL115658

C=C(C)C(=O)OCCOC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.46
THRB P10828 1/20 0.45
POLB P06746 1/20 0.43
APEX1 P27695 1/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 4/20 0.40
DUT P33316 1/20 0.39
ELANE P08246 1/20 0.39
SLC6A1 P30531 1/20 0.39
TK2 O00142 3/20 0.38
HRH4 Q9H3N8 1/20 0.38
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
TK1 P04183 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28173347 0.91 TDP1 (0.51) KIF11THRBPOLBAPEX1HTT
SCHEMBL24312367 0.91 TDP1 (0.48) KIF11THRBPOLBAPEX1HTT
SCHEMBL11054828 0.84 THRB (0.45) THRBPOLBAPEX1HTTTDP1
SCHEMBL22711060 0.84 THRB (0.45) THRBPOLBAPEX1HTTTDP1
SCHEMBL16078201 0.84 THRB (0.43) KIF11THRBPOLBAPEX1HTT
SCHEMBL19393417 0.83 KIF11 (0.52) KIF11TSHRDUTSLC6A1TK2
SCHEMBL16081493 0.83 THRB (0.40) KIF11THRBPOLBAPEX1HTT
SCHEMBL19012586 0.82 THRB (0.44) THRBPOLBAPEX1HTTTDP1
SCHEMBL871073 0.81 CYP2C19 (0.41) THRBPOLBAPEX1HTTTDP1
SCHEMBL9848763 0.81 CES1 (0.51) THRBPOLBAPEX1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107155328-A Constituent for display seal material, the organic protection layer containing it and contain its display equipment 三星SDI株式会社 2017-09-12 CN claimed
CN-107075033-A Constituent for display seal material, the organic protection layer containing it, contain its display equipment 三星SDI株式会社 2017-08-18 CN claimed
US-10756139-B2 Organic light emitting display SAMSUNG SDI CO., LTD. (KR) 2020-08-25 US disclosed
US-10727443-B2 Organic light emitting display SAMSUNG SDI CO., LTD. (KR) 2020-07-28 US disclosed
US-10700133-B2 Organic light emitting display SAMSUNG SDI CO., LTD. (KR) 2020-06-30 US disclosed
US-10570220-B2 Composition for display sealing material, organic protection layer comprising same, and display device comprising same SAMSUNG SDI CO., LTD. (KR) 2020-02-25 US disclosed
US-10316112-B2 Composition for display sealing material, organic protection layer comprising same, and display device comprising same SAMSUNG SDI CO., LTD. (KR) 2019-06-11 US disclosed
US-20180158880-A1 ORGANIC LIGHT EMITTING DISPLAY SAMSUNG SDI CO., LTD. (KR) 2018-06-07 US disclosed
US-20180158880-A1 ORGANIC LIGHT EMITTING DISPLAY SAMSUNG SDI CO., LTD. (KR) 2018-06-07 US disclosed
US-20180158879-A1 ORGANIC LIGHT EMITTING DISPLAY SAMSUNG SDI CO., LTD. (KR) 2018-06-07 US disclosed
US-20180158879-A1 ORGANIC LIGHT EMITTING DISPLAY SAMSUNG SDI CO., LTD. (KR) 2018-06-07 US disclosed
US-20090079784-A1 IMAGE FORMING METHOD AND APPARATUS FUJIFILM CORPORATION (JP) 2009-03-26 US disclosed
US-20090079784-A1 IMAGE FORMING METHOD AND APPARATUS FUJIFILM CORPORATION (JP) 2009-03-26 US disclosed
US-20080003288-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2008-01-03 US disclosed
US-7204997-B2 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2007-04-17 US disclosed
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
US-20030152623-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2003-08-14 US disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10316112-B2 Composition for display sealing material, organic protection layer comprising same, and display device comprising same ICAM1, CD40LG, VCAM1 KIF11 4140/4885THRB 3274/4885POLB 3582/4885
US-10570220-B2 Composition for display sealing material, organic protection layer comprising same, and display device comprising same TRPA1, ALKBH1, AHCYL1 KIF11 4503/4885THRB 4747/4885POLB 2578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.